Mohammad Zeeshan Najm

Dr. Mohammad Zeeshan Najm

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
Mohd Adnan KausarMohd Adnan Kausar
Mohd Adnan Kausar
SASadaf Anwar
Sadaf Anwar
YKYusuf S Khan
Yusuf S Khan
ASAyman Saleh
Ayman Saleh
MAMai Ali Abdelfattah Ahmed
Mai Ali Abdelfattah Ahmed
MNMohammad Zeeshan Najm
Mohammad Zeeshan Najm
Autophagy is a critical cellular process that maintains homeostasis by recycling damaged or aberrant components. This process is orchestrated by a network of proteins that form autophagosomes, which engulf and degrade intracellular material. In cancer, autophagy plays a dual role: it suppresses tumor initiation in the early stages but supports tumor growth and survival in advanced stages. Chronic myeloid leukemia (CML), a hematological malignancy, is characterized by the Philadelphia chromosome, a chromosomal abnormality resulting from a translocation between chromosomes 9 and 22. Autophagy has emerged as a key factor in CML pathogenesis, promoting cancer cell survival and contributing to resistance against tyrosine kinase inhibitors (TKIs), the primary treatment for CML. Targeting autophagic pathways is being actively explored as a therapeutic approach to overcome drug resistance and enhance cancer cell death. Recent research highlights the intricate interplay between autophagy and CML progression, underscoring its role in disease biology and treatment outcomes. This review aims to provide a comprehensive analysis of the molecular and cellular mechanisms underlying CML, with a focus on the therapeutic potential of targeting autophagy.

1 July 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
AAAbdulaziz Asiri
Abdulaziz Asiri
BBBayan T. Bokahri
Bayan T. Bokahri
AEAlaa Abdulaziz Eisa
Alaa Abdulaziz Eisa
HAHashim M. Aljohani
Hashim M. Aljohani
WNWesam Nofal
Wesam Nofal
MNMohammad Zeeshan Najm
Mohammad Zeeshan Najm
Cervical cancer (CC) continues to be the major cause of death from cancer in women worldwide and highlights the necessity for novel therapeutic approaches that target key oncogenic pathways. Conventional treatments, including chemotherapy and radiotherapy, exhibit significant limitations, including drug resistance, toxicity, and limited durability of response, highlighting the need for improved strategies. In recent years, Phytochemicals like curcumin, EGCG, and apigenin have demonstrated potent anticancer effects by modulating multiple dysregulated pathways in CC. These natural compounds exhibit multi-targeted effects, influencing signaling cascades such as PI3K/Akt, JAK/STAT, Wnt/β-catenin, and NF-κB, which drive tumor progression and metastasis. While plant-derived compounds like curcumin, EGCG, and apigenin have shown promising anticancer effects in preclinical models, there is a critical lack of comprehensive reviews that integrate mechanistic insights, clinical progress, and bioavailability challenges. Specifically, gaps remain in correlating these compounds’ modulation of cervical cancer-relevant signaling pathways with clinical outcomes, as well as in synthesizing recent innovations in nanotechnology that enhance their pharmacokinetics. A comparative evaluation highlights their mechanistic overlaps in regulating oncogenic signaling and their potential for synergistic combinations with conventional therapies to enhance treatment efficacy and overcome drug resistance. While bioavailability and systemic stability hinder clinical translation, advancements in nanotechnology and targeted delivery systems offer promising solutions. Future research should prioritize optimizing formulations and conducting large-scale clinical studies to facilitate the integration of plant bioactives into CC therapy, ultimately improving patient outcomes. Despite increasing interest in phytochemicals for cervical cancer treatment, current literature lacks comprehensive synthesis of studies addressing their molecular mechanisms, clinical efficacy, and novel strategies such as nanotechnology to enhance bioavailability.

9 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Mohd Adnan KausarMohd Adnan Kausar
Mohd Adnan Kausar
TBTulika Bhardwaj
Tulika Bhardwaj
SASadaf Anwar
Sadaf Anwar
FAFAHAAD Alenazi
FAHAAD Alenazi
AAAbrar Ali
Abrar Ali
MNMohammad Zeeshan Najm
Mohammad Zeeshan Najm
The burden of allergic illnesses is continuously rising, and patient diagnosis is a significant problem because of how intricately hereditary and environmental variables interact. The past three to four decades have seen an outbreak of allergies in high-income countries. According to reports on the illness, asthma affects around 300 million individuals worldwide. Identifying clinically important allergens for the accurate classification of IgE-mediated allergy respiratory disease diagnosis would be beneficial for implementing standardized allergen-associated therapy. Therefore, the current study includes an in silico analysis to identify potential IgE-mediated allergens in date palms and cockroaches. Such an immunoinformatic approach aids the prioritization of allergens with probable involvement in IgE-mediated allergic respiratory diseases. Immunoglobulin E (IgE) was used for molecular dynamic simulations, antigen–antibody docking analyses, epitope identifications, and characterizations. The potential of these allergens (Per a7, Per a 1.0102, and Bla g 1.0101) in IgE-mediated allergic respiratory diseases was explored through the evaluation of physicochemical characteristics, interaction observations, docking, and molecular dynamics simulations for drug and vaccine development.

5 August 2022 in Molecules
Verified
Journal Article
Open access
PDF file
Mohd Adnan KausarMohd Adnan Kausar
Mohd Adnan Kausar
SASadaf Anwar
Sadaf Anwar
WEWafa Ali Eltayb
Wafa Ali Eltayb
MKMohammed Kuddus
Mohammed Kuddus
FKFahmida Khatoon
Fahmida Khatoon
Mohnad AbdallaMohnad Abdalla
Mohnad Abdalla
Diabetes is emerging as an epidemic and is becoming a public health concern worldwide. Diabetic nephropathy is one of the serious complications of diabetes, and about 40% of individuals with diabetes develop diabetic nephropathy. The consistent feature of diabetes and its associated nephropathy is hyperglycemia, and in some cases, hyperamylinemia. Currently, the treatment includes the use of medication for blood pressure control, sugar control, and cholesterol control, and in the later stage requires dialysis and kidney transplantation, making the management of this complication very difficult. Bioactive compounds, herbal medicines, and extracts are extensively used in the treatment and prevention of several diseases, and some are reported to be efficacious in diabetes too. Therefore, in this study, we tried to identify the therapeutic potential of phytochemicals used in in silico docking and molecular dynamic simulation studies using a library of 5284 phytochemicals against the two potential targets of type 2 diabetes-associated nephropathy. We identified two phytochemicals (i.e., gentisic acid and michelalbine) that target human amylin peptide and dipeptidyl peptidase-4, respectively, with good binding affinity. These phytochemicals can be further evaluated using in vitro and in vivo studies for their anti-hyperglycemia and anti-hyperamylinemia effects.

29 May 2013 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
MNMohammad Zeeshan Najm
Mohammad Zeeshan Najm
SZShuaib Zaidi
Shuaib Zaidi
WSWaseem A Siddiqui
Waseem A Siddiqui
SHSyed Akhtar Husain
Syed Akhtar Husain

10 June 2022 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
TATaruna Arora
Taruna Arora
Mohd Adnan KausarMohd Adnan Kausar
Mohd Adnan Kausar
SAShimaa Mohammed Aboelnaga
Shimaa Mohammed Aboelnaga
SASadaf Anwar
Sadaf Anwar
MHMalik Asif Hussain
Malik Asif Hussain
AAAbdulaziz A. Aloliqi
Abdulaziz A. Aloliqi
Cancer is recognized as the leading cause of death worldwide. The hippo signaling pathway regulates organ size by balancing cell proliferation and cell death; hence dysregulation of the hippo pathway promotes cancer‑like conditions. miRNAs are a type of non‑coding RNA that have been shown to regulate gene expression. miRNA levels are altered in various classes of cancer. Researchers have also uncovered a crosslinking between miRNAs and the hippo pathway, which has been linked to cancer. The components of the hippo pathway regulate miRNA synthesis, and various miRNAs regulate the components of the hippo pathway both positively and negatively, which can lead to cancer‑like conditions. In the present review article, the mechanism behind the hippo signaling pathway and miRNAs biogenesis and crosslinks between miRNAs and the hippo pathway, which result in cancer, shall be discussed. Furthermore, the article will cover miRNA‑related therapeutics and provide an overview of the development of resistance to anticancer drugs. Understanding the underlying processes would improve the chances of developing effective cancer treatment therapies.